North America Cardiovascular Devices Market Outlook to 2017

Sep 12, 2011, 05:01 ET from Reportlinker

NEW YORK, Sept. 12, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

North America Cardiovascular Devices Market Outlook to 2017

http://www.reportlinker.com/p0336531/North-America-Cardiovascular-Devices-Market-Outlook-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices

North America Cardiovascular Devices Market Outlook to 2017

Summary

GlobalData's new report, "North America Cardiovascular Devices Market Outlook to 2017" provides key market data on the North America Cardiovascular Devices market – Canada and United States. The report provides value (USD million) data for all the market categories – Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include Canada and United States.

- Market size and company share data for Cardiovascular Devices market categories – Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves.

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the North America Cardiovascular Devices market..

- Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Abbott Laboratories, Cordis Corporation, C. R. Bard, Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the North America Cardiovascular Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 13

1.2 List of Figures 17

2 Introduction 19

2.1 What is This Report About? 19

3 Cardiovascular Devices in North America 20

3.1 Cardiovascular Devices Cross Country Comparison, Revenue ($m), 2003-2017 20

3.2 Cardiovascular Devices, North America, Overall Revenue ($m), 2003-2017 21

3.3 Cardiovascular Devices, North America, Category Volume (Units), 2003-2017 29

3.4 Cardiovascular Devices, North America, Company share (2009-2010) 35

4 Cardiovascular Devices In United States 37

4.1 Cardiovascular Devices, United States, Overall Revenue ($m), 2003-2017 37

4.2 Cardiovascular Devices, United States, Category Volume (Units), 2003-2017 43

4.3 Cardiovascular Devices, United States, Distribution Share (2009-2010) 49

4.3.1 Cardiac Assist Devices, United States, Distribution Share (2009-2010) 49

4.3.2 Cardiac Rhythm Management, United States, Distribution Share (2009-2010) 49

4.3.3 Cardiovascular Monitoring and Diagnostic Devices, United States, Distribution Share (2009-2010) 50

4.3.4 Cardiovascular Prosthetic Devices, United States, Distribution Share (2009-2010) 50

4.3.5 Cardiovascular Surgery, United States, Distribution Share (2009-2010) 51

4.3.6 Electrophysiology Distribution Share (2009-2010) 51

4.3.7 External Defibrillators, United States, Distribution Share (2009-2010) 52

4.3.8 Interventional Cardiology, United States, Distribution Share (2009-2010) 52

4.3.9 Peripheral Vascular Devices, United States, Distribution Share (2009-2010) 53

4.3.10 Prosthetic Heart Valves, United States, Distribution Share (2009-2010) 53

4.4 Cardiovascular Devices, United States, Company Share (2009-2010) 54

4.4.1 Cardiovascular Devices, United States, Company Share (2009-2010) 54

4.4.2 Cardiac Assist Devices, United States, Company Share (2009-2010) 56

4.4.3 Cardiac Rhythm Management, United States, Company Share (2009-2010) 58

4.4.4 Cardiovascular Monitoring and Diagnostic Devices, United States, Company Share (2009-2010) 60

4.4.5 Cardiovascular Prosthetic Devices, United States, Company Share (2009-2010) 62

4.4.6 Cardiovascular Surgery, United States, Company Share (2009-2010) 64

4.4.7 Electrophysiology, United States, Company Share (2009-2010) 66

4.4.8 External Defibrillators, United States, Company Share (2009-2010) 68

4.4.9 Interventional Cardiology, United States, Company Share (2009-2010) 69

4.4.10 Peripheral Vascular Devices, United States, Company Share (2009-2010) 73

4.4.11 Prosthetic Heart Valves, United States, Company Share (2009-2010) 75

5 Cardiovascular Devices In Canada 77

5.1 Cardiovascular Devices, Canada, Overall Revenue ($m), 2003-2017 77

5.2 Cardiovascular Devices, Canada, Category Volume (Units), 2003-2017 83

5.3 Cardiovascular Devices, Canada, Distribution Share (2009-2010) 89

5.3.1 Cardiac Assist Devices, Canada, Distribution Share (2009-2010) 89

5.3.2 Cardiac Rhythm Management, Canada, Distribution Share (2009-2010) 89

5.3.3 Cardiovascular Monitoring and Diagnostic Devices, Canada, Distribution Share (2009-2010) 90

5.3.4 Cardiovascular Prosthetic Devices, Canada, Distribution Share (2009-2010) 90

5.3.5 Cardiovascular Surgery, Canada, Distribution Share (2009-2010) 91

5.3.6 Electrophysiology, Canada, Distribution Share (2009-2010) 91

5.3.7 External Defibrillators, Canada, Distribution Share (2009-2010) 92

5.3.8 Interventional Cardiology, Canada, Distribution Share (2009-2010) 92

5.3.9 Peripheral Vascular Devices, Canada, Distribution Share (2009-2010) 93

5.3.10 Prosthetic Heart Valves, Canada, Distribution Share (2009-2010) 93

5.4 Cardiovascular Devices, Canada, Company Share (2009-2010) 94

5.4.1 Cardiovascular Devices, Canada, Company Share (2009-2010) 94

5.4.2 Cardiac Assist Devices, Canada, Company Share (2009-2010) 96

5.4.3 Cardiac Rhythm Management, Canada, Company Share (2009-2010) 97

5.4.4 Cardiovascular Monitoring and Diagnostic Devices, Canada, Company Share (2009-2010) 98

5.4.5 Cardiovascular Prosthetic Devices, Canada, Company Share (2009-2010) 100

5.4.6 Cardiovascular Surgery, Canada, Company Share (2009-2010) 102

5.4.7 Electrophysiology, Canada, Company Share (2009-2010) 104

5.4.8 External Defibrillators, Canada, Company Share (2009-2010) 106

5.4.9 Interventional Cardiology, Canada, Company Share (2009-2010) 108

5.4.10 Peripheral Vascular Devices, Canada, Company Share (2009-2010) 112

5.4.11 Prosthetic Heart Valves, Canada, Company Share (2009-2010) 114

6 Overview of Key Companies in North America Cardiovascular Devices Market 116

6.1 Medtronic, Inc. 116

6.1.1 Company Overview 116

6.1.2 Share in the North America Cardiovascular Devices Market 116

6.2 Boston Scientific Corporation 117

6.2.1 Company Overview 117

6.2.2 Share in the North America Cardiovascular Devices Market 117

6.3 St. Jude Medical, Inc. 118

6.3.1 Company Overview 118

6.3.2 Share in the North America Cardiovascular Devices Market 118

6.4 Abbott Laboratories 119

6.4.1 Company Overview 119

6.4.2 Share in the North America Cardiovascular Devices Market 119

6.5 Cordis Corporation 120

6.5.1 Company Overview 120

6.5.2 Share in the North America Cardiovascular Devices Market 120

6.6 C. R. Bard, Inc. 121

6.6.1 Company Overview 121

6.6.2 Share in the North America Cardiovascular Devices Market 121

6.7 Thoratec Corporation 122

6.7.1 Company Overview 122

6.8 Philips Healthcare 122

6.8.1 Company Overview 122

6.9 Edwards Lifesciences Corporation 122

6.9.1 Company Overview 122

6.10 ZOLL Medical Corporation 123

6.10.1 Company Overview 123

6.11 MAQUET GmbH & Co. KG 123

6.11.1 Company Overview 123

6.12 Covidien plc 123

6.12.1 Company Overview 123

6.13 Terumo Corporation 124

6.13.1 Company Overview 124

6.14 Biosense Webster, Inc. 124

6.14.1 Company Overview 124

6.15 BIOTRONIK SE & Co. KG 124

6.15.1 Company Overview 124

6.16 GE Healthcare 125

6.16.1 Company Overview 125

6.17 Volcano Corporation 125

6.17.1 Company Overview 125

6.18 Cardiac Science Corporation 125

6.18.1 Company Overview 125

6.19 AGA Medical Holdings, Inc. 126

6.19.1 Company Overview 126

6.20 Welch Allyn Inc. 126

6.20.1 Company Overview 126

6.21 ev3 Inc. 126

6.21.1 Company Overview 126

6.22 OSI Systems, Inc. 127

6.22.1 Company Overview 127

6.23 Goodman Co., Ltd. 127

6.23.1 Company Overview 127

6.24 CareFusion Corporation 128

6.24.1 Company Overview 128

6.25 Card Guard Scientific Survival, Ltd. 128

6.25.1 Company Overview 128

6.26 Berlin Heart GmbH 128

6.26.1 Company Overview 128

6.27 HeartWare International, Inc. 129

6.27.1 Company Overview 129

6.28 Mortara Instrument, Inc. 129

6.28.1 Company Overview 129

6.29 Teleflex Incorporated 129

6.29.1 Company Overview 129

6.30 Schiller AG 130

6.30.1 Company Overview 130

6.31 ABIOMED, Inc. 130

6.31.1 Company Overview 130

7 Cardiovascular Devices Market Pipeline Products 131

7.1 Cardiac Assist Devices Market Pipeline Products 131

7.1.1 Ventricular Assist Devices Market Pipeline Products 131

7.1.2 Total Artificial Heart Market Pipeline Products 132

7.2 Cardiac Rhythm Management Market Pipeline Products 133

7.2.1 Implantable Cardioverter Defibrillator Market Pipeline Products 133

7.2.2 Pacemaker Market Pipeline Products 134

7.2.3 Implantable Cardioverter Defibrillators Market Pipeline Products 135

7.3 Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products 136

7.4 Cardiovascular Prosthetic Devices Market Pipeline Products 139

7.4.1 Cardiac Valve Repairs Market Pipeline Products 139

7.4.2 Septal Occluders Market Pipeline Products 140

7.5 Cardiovascular Surgery Market Pipeline Products 141

7.6 Electrophysiology Market Pipeline Products 143

7.6.1 Electrophysiology Ablation Catheters Market Pipeline Products 143

7.6.2 Electrophysiology Diagnostic Catheters Market Pipeline Products 145

7.6.3 Electrophysiology Lab Systems Market Pipeline Products 145

7.7 Interventional Cardiology Market Pipeline Products 146

7.7.1 Coronary Stents Market Pipeline Products 146

7.7.2 PTCA Balloon Market Pipeline Products 150

7.7.3 Cardiac Catheter Market Pipeline Products 151

7.7.4 Coronary Guidewire Market Pipeline Products 151

7.7.5 Arteriotomy Closure Devices Market Pipeline Products 152

7.7.6 PTCA Coronary Drug Eluting Balloons (DEB) Market Pipeline Products 153

7.7.7 Intravascular Ultrasound Systems (IVUS) Market Pipeline Products 154

7.8 Peripheral Vascular Devices Market Pipeline Products 155

7.8.1 Stent Grafts Market Pipeline Products 155

7.8.2 Peripheral Vascular Stents Market Pipeline Products 157

7.8.3 PTA Balloons Market Pipeline Products 159

7.8.4 Synthetic Surgical Grafts Market Pipeline Products 160

7.8.5 Peripheral Guidewires Market Pipeline Products 160

7.8.6 Inferior Vena Cava Filters (IVCF) Market Pipeline Products 161

7.8.7 Peripheral Embolic Protection Devices Market Pipeline Products 162

7.8.8 PTA Peripheral Drug Eluting Balloons (DEB) Market Pipeline Products 163

7.9 Prosthetic Heart Valves Market Pipeline Products 164

7.9.1 Tissue Heart Valves Market Pipeline Products 164

7.9.2 Mechanical Heart Valves Market Pipeline Products 165

7.9.3 Transcatheter Heart Valves Market Pipeline Products 166

8 Financial Deals Landscape 167

8.1 Acquisition 167

8.1.1 ValveXchange Receives Equity Investment from CryoLife 167

8.1.2 Flexible Stenting Solutions Receives Investment From Goodman 169

8.1.3 St. Jude Medical To Invest In Nanostim 170

8.1.4 Toshiba Medical Systems Completes Tender Offer To Acquire Vital Images For $273 Million 171

8.1.5 Baxter International To Acquire Prism Pharmaceuticals 173

8.1.6 Quest Diagnostics Completes Acquisition Of Celera 175

8.1.7 Biomedical Structures Acquires Concordia Medical 178

8.1.8 Veniti to Acquire Varix Medical and Teneo Medical 179

8.1.9 Physio-Control Acquires Jolife 180

8.1.10 Medtronic to Sell Physio-Control 182

8.1.11 Boston Scientific Acquires ReVascular Therapeutics 183

8.1.12 Cybersonics Acquires Omnisonics Medical Technologies 184

8.1.13 Boston Scientific Completes Acquisition Of Atritech 185

8.1.14 Teleflex Acquires VasoNova 187

8.1.15 Edwards Lifesciences Completes Acquisition Of Embrella Cardiovascular 189

8.1.16 Medtronic Completes Acquisition Of Remaining Stake In Ardian 191

8.1.17 Boston Scientific Completes Acquisition Of Remaining Stake In Sadra Medical 193

8.2 Partnerships 196

8.2.1 Bioheart Enters Into Licensing Agreement With Airspeed Equity 196

8.2.2 Vicor Technologies Enters Into Licensing Agreement With ZOLL Medical 197

8.2.3 NSVascular Enters Into Licensing Agreement With University of California 198

8.2.4 LiDCO Signs Licensing Agreement With ICU Medical 199

8.2.5 Aria CV Enters Into Licensing Agreement With University Of Minnesota 200

8.2.6 Christie Medical Enters Into An Agreement With Eclipse Aesthetics 201

8.2.7 Luna Innovations Expands Its Licensing Agreement With Hansen Medical 202

8.2.8 Accumetrics Signs Distribution Agreement With Cardinal Health 203

8.2.9 Rhythmia Medical Enters Into Joint Development Agreement With Endosense 204

8.2.10 Acacia Research Enters Into Licensing Agreement With SMITHS MEDICAL ASD 205

8.2.11 Acacia Research Enters Into Licensing Agreement With Becton, Dickinson And Argon Medical 206

8.2.12 International Cardio Enters Into Licensing Agreement With University of Minnesota 207

8.2.13 Boston Scientific Enters Into Partnership With Greatbatch Medical 208

8.2.14 American Hospital Management Enters Into Joint Venture Agreement With Royal St. Kitts Beach Resort 209

8.2.15 Physio-Control Enters Into Strategic Partnership With BeneChill 210

8.2.16 APICA Cardiovascular Enters Into Licensing Agreement With Georgia Institute And Emory University 211

9 Recent Developments 212

9.1 Strategy and Business Planning 212

9.1.1 Jul 29, 2011: WorldHeart to End Levacor VAD Program 212

9.1.2 Jun 27, 2011: Cook Medical Expands Asia-Pacific Distribution Centre In China To Meet Regional Surge In Growth Of Medical Device Market 212

9.1.3 Jun 15, 2011: Cordis Announces Discontinuation Of NEVO Sirolimus-Eluting Coronary Stent 213

9.1.4 May 20, 2011: LeMaitre To Consolidate California Factory 213

9.1.5 May 09, 2011: Cook Expands Raw Materials Manufacturing To Canton, Illinois 214

9.1.6 May 05, 2011: Medtronic Opens New Distribution Center In Mira Loma, California 215

9.1.7 Mar 08, 2011: Medtronic Inaugurates New Regional Headquarters Building In Greater China 215

9.1.8 Feb 10, 2011: C. R. Bard To Reduce Workforce By 20% 216

9.1.9 Feb 10, 2011: J&J Cordis Reduces Workforce In US 216

9.1.10 Jan 27, 2011: Greatbatch Medical To Build New Facility In Fort Wayne 216

9.1.11 Jan 10, 2011: Vasomedical Launches Online Store 216

9.1.12 Dec 13, 2010: Bard To Improve Overall Cost Structure And Enhance Operational Effectiveness 217

9.1.13 Nov 30, 2010: Hansen Opens European Commercialization And Training Center 217

9.1.14 Nov 09, 2010: Medtronic Opens New Distribution Center In Elizabeth, New Jersey 218

9.1.15 Oct 21, 2010: Collagen Matrix Expands Operations And Moves Corporate Headquarters To Oakland, New Jersey 218

9.1.16 Oct 14, 2010: SurModics Announces Organizational Changes To Reduce Cost Structure And Renew Focus On Business Units 218

9.1.17 Oct 07, 2010: AT&T, eCardio Team Up To Advance Cardiac Care Through Innovative Mobile Technology 219

9.1.18 Oct 04, 2010: Edwards Lifesciences Opens New Facility In Utah 220

9.1.19 Sep 29, 2010: Edwards Lifesciences To Open New Manufacturing Facility In Utah 220

9.1.20 Sep 24, 2010: Merit Medical To Commence Construction Of New Building On South Jordan Campus 221

9.1.21 Aug 19, 2010: Boston Scientific To Invest In New Products: CEO 221

9.1.22 Aug 16, 2010: Orchid Expands Cleaning And Packaging Capabilities In Southfield, Michigan 221

9.1.23 Aug 09, 2010: Orthofix To Open New North American Operations And Education Center In Texas 222

9.2 Legal and Regulatory 223

9.2.1 Jul 12, 2011: Acacia Subsidiary Enters Into Settlement Agreement With Boston Scientific 223

9.2.2 Jun 07, 2011: Boston Scientific Gets Favorable Court Ruling Affirming Invalidity Of J&J Patents 223

9.2.3 May 24, 2011: Jensen Law Firm Announces $10m Verdict Against Johnson & Johnson Unit For Toxic Motrin Reaction 223

9.2.4 May 11, 2011: Boston Scientific Announces Favorable Jury Verdict Against Cordis In Stent Patent Litigation 224

9.2.5 May 03, 2011: U.S. Senate Finance Committee Announces Investigation Against Medtronic 224

9.2.6 Apr 27, 2011: Acacia Subsidiary Enters Into Settlement Agreement With Cordis 224

9.2.7 Apr 25, 2011: St. Jude Medical Wins $2.3 Billion In Trade Secret Infringement Lawsuit Against Nervicon 224

9.2.8 Apr 07, 2011: J&J To Pay $70m To Settle Cases Brought By SEC And Criminal Authorities 224

9.2.9 Feb 08, 2011: Medtronic Issues Statement On District Court Ruling Regarding CoreValve 225

9.2.10 Feb 08, 2011: Edwards Lifesciences Issues Statment Regarding US Court Ruling 225

9.2.11 Jan 28, 2011: Boston Scientific Responds To DOJ Civil Lawsuit 226

9.2.12 Jan 28, 2011: Federal Jury In Marshall, Texas Returns $482 Million Verdict For Dickstein Shapiro Client 226

9.2.13 Jan 27, 2011: US Files Suit Against Guidant And Boston Scientific For Selling Defective Heart Devices That Were Implanted In Medicare Patients 226

9.2.14 Jan 20, 2011: St. Jude Medical Reaches Settlement With DOJ 227

9.2.15 Jan 12, 2011: Guidant To Pay Criminal Penalty Of More Than $296 Million And Three Years Probation 228

9.2.16 Jan 11, 2011: Boston Scientific Reaches Settlement With Medinol 228

9.2.17 Jan 07, 2011: Judge Dismisses Class Action Lawsuit Against Medtronic Over Product Problem Issues 229

9.2.18 Dec 09, 2010: VNUS Reports Jury Returns Verdict In VNUS' Lawsuit With TVS And biolitec 229

9.2.19 Nov 10, 2010: St. Jude Medical And AGA Medical Announce Early Termination Of HSR Waiting Period 229

9.2.20 Nov 02, 2010: CSI Settles Employee Lawsuit With ev3 230

9.2.21 Nov 01, 2010: Ela Medical To Pay $9.2 Million To Resolve Kickbacks Claims 230

9.2.22 Nov 01, 2010: AGA Medical Investor Files Lawsuit Against Buyout 230

9.2.23 Oct 22, 2010: Sorin Announces Full And Final Settlement Of Investigation By DOJ 231

9.2.24 Oct 19, 2010: Howard G. Smith Investigates Proposed Acquisition Of Cardiac Science By OCI 231

9.2.25 Oct 18, 2010: Robbins Umeda Investigates Acquisition Of AGA Medical By St. Jude Medical 232

9.2.26 Oct 14, 2010: Medtronic Settles US Lawsuits On Sprint Fidelis Family Of Defibrillation Leads 232

9.2.27 Oct 04, 2010: Guide Flow Sues Six Companies Over Catheter Patent 232

9.2.28 Oct 04, 2010: Wall Cardiovascular Settles With Medtronic, Boston Scientific Over Stent Patent 233

9.2.29 Sep 28, 2010: Boston Scientific Urges Federal Court To Dismiss Guidant Lawsuit 233

9.2.30 Sep 23, 2010: St. Jude Medical Faces Derivative Suit From Shareholders 233

9.2.31 Sep 22, 2010: AIC Must Pay Out On $50 Million Policy In St. Jude Medical's Silzone Case 233

9.2.32 Sep 20, 2010: Volcano Files Counterclaim Asserting St. Jude Infringes Three Patents 234

9.2.33 Sep 20, 2010: ConMed Files Complaint Against Former Sales Consultant 234

9.2.34 Sep 16, 2010: Minnesota Appeals Court Denies Appeal Of Medtronic Sprint Fidelis Case 234

9.2.35 Aug 26, 2010: St. Jude Medical In Talks With DOJ Kickbacks Case 235

9.2.36 Aug 24, 2010: AGA Medical Sues W.L. Gore & Associates For Patent Infringement 235

9.2.37 Aug 24, 2010: AtriCure might Resolve Class Action Lawsuit For $2.8 Million 235

9.2.38 Aug 18, 2010: Atrium Responds To Bard Suit 235

9.2.39 Aug 11, 2010: CardioNet Provides Update On Class Action Litigation 236

9.2.40 Aug 11, 2010: Endologix Responds To Patent Infringement Disputes With Bard Peripheral 236

9.3 Government and Public Interest 236

9.3.1 Jul 18, 2011: BG Medicine Receives ISO 13485 Certification 236

9.3.2 Jul 13, 2011: New Method Defibrillates Heart With Less Electricity, Pain: Cornell University 237

9.3.3 Jul 11, 2011: Mayo Clinic's VAD Program Offers Hope For Heart Failure Patients 238

9.3.4 Jul 10, 2011: MGH Researchers Develop One-Micrometer-Resolution Version Of Intravascular Imaging Technology 239

9.3.5 Jun 29, 2011: Hospira Supports North Carolina's New Legislation Aimed At Reducing Healthcare-Associated Infections 240

9.3.6 Jun 28, 2011: New Study Shows Viability Of Heart Pumps For Older Heart-Failure Patients 240

9.3.7 Jun 27, 2011: Boston Scientific Applauds Passage Of Patent Reform Bill 241

9.3.8 Jun 24, 2011: Hospitals, Healthcare Providers To Benefit From New Premier Agreements For Invasive Hemodynamic Monitoring Products And Accessories 242

9.3.9 Jun 21, 2011: Spaulding Clinical Quality Management System Achieves ISO 13485 Certification 242

9.3.10 Jun 20, 2011: Teleflex Resolves FDA Corporate Warning Letter 242

9.3.11 Jun 14, 2011: FDA Recalls Boston Scientific's Atlantis SR Pro2 Coronary Imaging Catheters In Addition To iCross Catheters 243

9.3.12 Jun 13, 2011: Echocardiography Shows Promise In Guiding Gene Therapy For Disease Prevention And Treatment 243

9.3.13 May 26, 2011: Drug-Eluting Stents Using Biodegradable Polymer Significantly Improve Overall Clinical Outcomes 243

9.3.14 May 06, 2011: Study Shows Stents Are Superior To Balloons Alone For Patients With Deep Venous Thrombosis 244

9.3.15 May 05, 2011: SCAI Releases First Report On Transradial Access For Angioplasty And Stenting 245

9.3.16 May 05, 2011: HERCULES Trial Demonstrates Significant Reduction In Systolic Blood Pressure While Revealing Marker In Hypertensive Patients Does Not Predict Outcomes Of Renal Artery Stenting 245

9.3.17 May 05, 2011: Specialized Signals Inside ICDs Provide Ongoing Monitoring For High-Risk Patients: Study 246

9.3.18 May 03, 2011: Premier, BIOTRONIK To Offer Savings Opportunities For CRM Devices 247

9.3.19 Apr 29, 2011: Defibtech Announces Voluntary Recall Of DDU-100 Series AEDs 248

9.3.20 Apr 27, 2011: CareCore National Recommends Adoption of Prior Authorization to Improve Patient Outcomes And Curb Healthcare Spend 248

9.3.21 Apr 16, 2011: New Patient Guidelines for Heart Devices Presented At International Society Of Heart And Lung Transplantation Annual Meeting 249

9.3.22 Apr 14, 2011: Progress In Development Of Mechanical Circulatory Support Devices For Children To Be Presented At ISHLT Annual Meeting 249

9.3.23 Apr 14, 2011: St Jude Medical Receives FDA And CE Mark Approvals For ShockGuard Technology 250

9.3.24 Apr 11, 2011: Philips Medical Systems Receives Amended Warning Letter From FDA 250

9.3.25 Apr 03, 2011: New Study Shows Aortic Valve Replacement Via Catheter Produces Better Outcomes Than Traditional Open-Heart Surgery 251

9.3.26 Mar 23, 2011: Mayo Clinic Researchers Find Cardiac Pacing Helps Epilepsy Patients With Ictal Asystole 252

9.3.27 Mar 22, 2011: Terumo Cardiovascular Systems Reaches Agreement on Terms of Consent Decree with FDA Regarding Quality System Improvements 253

9.3.28 Mar 21, 2011: Millar Instruments Issues Recall Of Millar Mikro-Tip Angiographic Catheter, Model SPC-454D And SPC-454F 253

9.3.29 Mar 14, 2011: Winthrop-University Hospital Implants Revo MRI Surescan Pacing System 254

9.3.30 Mar 09, 2011: Medtronic Resolves FDA Warning Letters 255

9.3.31 Mar 03, 2011: Analysis Of SAPPHIRE Data In March Issue Of CCI Supports CAS As Cost-Effective Alternative To CEA 255

9.3.32 Mar 01, 2011: Women Get Short Shrift In Many Heart Device Studies, Despite Requirement: Study 256

9.3.33 Feb 03, 2011: Abiomed Announces Survey Results And Launches National Heart Recovery Awareness Campaign 257

9.3.34 Jan 26, 2011: Texas Heart Institute At St. Luke's Episcopal Hospital First In Texas To Offer New Cardiology Procedure To Eliminate A Major Cause Of Heart-Related Stroke 257

9.3.35 Jan 25, 2011: Occurrence Of Stroke After CABG Surgery Appears To Be Decreasing: Study 258

9.3.36 Jan 24, 2011: University Of Michigan, University Of Pittsburgh To Lead REVIVE-IT Study With $13.3 Million In Support From NHLBI, HeartWare 259

9.3.37 Jan 21, 2011: FDA To Implement Stricter Approval Process For Defibrillators 260

9.3.38 Jan 20, 2011: Spectranetics Receives FDA Approval For Site Change Related To Manufacturing Of CVX-300 Laser System 260

9.3.39 Jan 19, 2011: SCAI Publishes Radiation Safety Program Principles For Cardiac Catheterization Labs 261

9.3.40 Jan 04, 2011: Many Patients With ICDs Do Not Meet Criteria For Use: JAMA Study 262

9.4 Product News 263

9.4.1 Jul 13, 2011: Toshiba Installs Infinix CF-i Bi-Plane System With CAT-880B Hybrid Catheterization Table At Arnold Palmer Hospital for Children In Orlando, Florida 263

9.4.2 Jul 12, 2011: Boston Scientific Completes Clinical Trial Enrollment For Adapt Monorail Carotid Stent System 264

9.4.3 Jan 21, 2011: Cardiac Science Extends Device Connectivity To Allscripts Professional Electronic Health Record 264

9.4.4 Oct 26, 2010: eCardio Plans To Streamline Products 265

9.4.5 Sep 10, 2010: CorMatrix Receives FDA IDE Approval To Begin Clinical Evaluation Of New Onset Postoperative Atrial Fibrillation In Subjects Receiving CorMatrix ECM For Pericardial Closure 265

9.4.6 Sep 01, 2010: ZOLL To Showcase LifeVest Wearable Defibrillator At The Heart Failure Society Of America Annual Meeting 266

9.4.7 Aug 04, 2010: Beaumont Hospital Physicians Screens High School Students Using GE Healthcare's MAC 800 ECG 267

9.4.8 Jul 20, 2010: Spectranetics Announces Reimbursement Approval For Laser-Assisted Lead Extraction In Japan 267

9.4.9 Jul 12, 2010: BIOTRONIK Unveils Final Results Of TRUST Trial For BIOTRONIK Home Monitoring 268

10 Appendix 270

10.1 Definitions of Markets Covered in the Report 271

10.1.1 Cardiovascular Devices 271

10.2 Research Methodology 273

10.3 Secondary Research 273

10.4 Primary Research 274

10.5 Models 274

10.6 Forecasts 275

10.7 Expert Panels 275

10.8 GlobalData Consulting 275

10.9 Currency Conversion 275

10.10 Contact Us 276

10.11 Disclaimer 276

1.1 List of Tables

Table 1: Cardiovascular Devices, Cross Country Comparison, Revenue ($m), 2003-2017 20

Table 2: Cardiovascular Devices, North America, Overall Revenue ($m), 2003-2017 22

Table 3: Cardiovascular Devices, North America, Cross-Category Analysis, 2003-2017 24

Table 4: Cardiovascular Devices, North America, Overall Revenue ($m), Historic, 2003-2010 26

Table 5: Cardiovascular Devices, North America, Overall Revenue ($m), Forecast, 2010-2017 28

Table 6: Cardiovascular Devices, North America, Category Volume (Units), 2003-2017 30

Table 7: Cardiovascular Devices, North America, Category Volume (Units), Historic, 2003-2010 32

Table 8: Cardiovascular Devices, North America, Category Volume (Units), Forecast, 2010-2017 34

Table 9: Cardiovascular Devices, North America, Company share by Revenue ($m), 2009-2010 36

Table 10: Cardiovascular Devices, United States, Overall Revenue ($m), 2003-2017 38

Table 11: Cardiovascular Devices, United States, Overall Revenue ($m), Historic, 2003-2010 40

Table 12: Cardiovascular Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 42

Table 13: Cardiovascular Devices, United States, Category Volume (Units), 2003-2017 44

Table 14: Cardiovascular Devices, United States, Category Volume (Units), Historic, 2003-2010 46

Table 15: Cardiovascular Devices, United States, Category Volume (Units), Forecast, 2010-2017 48

Table 16: Cardiac Assist Devices, United States, Distribution Share by Revenue ($m), 2009-2010 49

Table 17: Cardiac Rhythm Management, United States, Distribution Share by Revenue ($m), 2009-2010 49

Table 18: Cardiovascular Monitoring and Diagnostic Devices, United States, Distribution Share by Revenue ($m), 2009-2010 50

Table 19: Cardiovascular Prosthetic Devices, United States, Distribution Share by Revenue ($m), 2009-2010 50

Table 20: Cardiovascular Surgery, United States, Distribution Share by Revenue ($m), 2009-2010 51

Table 21: Electrophysiology, United States, Distribution Share by Revenue ($m), 2009-2010 51

Table 22: External Defibrillators, United States, Distribution Share by Revenue ($m), 2009-2010 52

Table 23: Interventional Cardiology, United States, Distribution Share by Revenue ($m), 2009-2010 52

Table 24: Peripheral Vascular Devices, United States, Distribution Share by Revenue ($m), 2009-2010 53

Table 25: Prosthetic Heart Valves, United States, Distribution Share by Revenue ($m), 2009-2010 53

Table 26: Cardiovascular Devices, United States, Company Share by Revenue ($m), 2009-2010 55

Table 27: Cardiac Assist Devices, United States, Company Share by Revenue ($m), 2009-2010 57

Table 28: Cardiac Rhythm Management, United States, Company Share by Revenue ($m), 2009-2010 59

Table 29: Cardiovascular Monitoring and Diagnostic Devices, United States, Company Share by Revenue ($m), 2009-2010 61

Table 30: Cardiovascular Prosthetic Devices, United States, Company Share by Revenue ($m), 2009-2010 63

Table 31: Cardiovascular Surgery, United States, Company Share by Revenue ($m), 2009-2010 65

Table 32: Electrophysiology, United States, Company Share by Revenue ($m), 2009-2010 67

Table 33: External Defibrillators, United States, Company Share by Revenue ($m), 2009-2010 68

Table 34: Interventional Cardiology, United States, Company Share by Revenue ($m), 2009-2010 70

Table 35: Cardiac Catheters, United States, Company Share by Revenue ($m), 2009-2010 71

Table 36: Coronary Stents, United States, Company Share by Revenue ($m), 2009-2010 72

Table 37: Peripheral Vascular Devices, United States, Company Share by Revenue ($m), 2009-2010 74

Table 38: Prosthetic Heart Valves, United States, Company Share by Revenue ($m), 2009-2010 76

Table 39: Cardiovascular Devices, Canada, Overall Revenue ($m), 2003-2017 78

Table 40: Cardiovascular Devices, Canada, Overall Revenue ($m), Historic, 2003-2010 80

Table 41: Cardiovascular Devices, Canada, Overall Revenue ($m), Forecast, 2010-2017 82

Table 42: Cardiovascular Devices, Canada, Category Volume (Units), 2003-2017 84

Table 43: Cardiovascular Devices, Canada, Category Volume (Units), Historic, 2003-2010 86

Table 44: Cardiovascular Devices, Canada, Category Volume (Units), Forecast, 2010-2017 88

Table 45: Cardiac Assist Devices, Canada, Distribution Share by Revenue ($m), 2009-2010 89

Table 46: Cardiac Rhythm Management, Canada, Distribution Share by Revenue ($m), 2009-2010 89

Table 47: Cardiovascular Monitoring and Diagnostic Devices, Canada, Distribution Share by Revenue ($m), 2009-2010 90

Table 48: Cardiovascular Prosthetic Devices, Canada, Distribution Share by Revenue ($m), 2009-2010 90

Table 49: Cardiovascular Surgery, Canada, Distribution Share by Revenue ($m), 2009-2010 91

Table 50: Electrophysiology, Canada, Distribution Share by Revenue ($m), 2009-2010 91

Table 51: External Defibrillators, Canada, Distribution Share by Revenue ($m), 2009-2010 92

Table 52: Interventional Cardiology, Canada, Distribution Share by Revenue ($m), 2009-2010 92

Table 53: Peripheral Vascular Devices, Canada, Distribution Share by Revenue ($m), 2009-2010 93

Table 54: Prosthetic Heart Valves, Canada, Distribution Share by Revenue ($m), 2009-2010 93

Table 55: Cardiovascular Devices, Canada, Company Share by Revenue ($m), 2009-2010 95

Table 56: Cardiac Assist Devices, Canada, Company Share by Revenue ($m), 2009-2010 96

Table 57: Cardiac Rhythm Management, Canada, Company Share by Revenue ($m), 2009-2010 97

Table 58: Cardiovascular Monitoring and Diagnostic Devices, Canada, Company Share by Revenue ($m), 2009-2010 99

Table 59: Cardiovascular Prosthetic Devices, Canada, Company Share by Revenue ($m), 2009-2010 101

Table 60: Cardiovascular Surgery, Canada, Company Share by Revenue ($m), 2009-2010 103

Table 61: Electrophysiology, Canada, Company Share by Revenue ($m), 2009-2010 105

Table 62: External Defibrillators, Canada, Company Share by Revenue ($m), 2009-2010 107

Table 63: Interventional Cardiology, Canada, Company Share by Revenue ($m), 2009-2010 109

Table 64: Cardiac Catheters, Canada, Company Share by Revenue ($m), 2009-2010 110

Table 65: Coronary Stents, Canada, Company Share by Revenue ($m), 2009-2010 111

Table 66: Peripheral Vascular Devices, Canada, Company Share by Revenue ($m), 2009-2010 113

Table 67: Prosthetic Heart Valves, Canada, Company Share by Revenue ($m), 2009-2010 115

Table 68: Ventricular Assist Devices Market Pipeline Products 131

Table 69: Total Artificial Heart Market Pipeline Products 132

Table 70: Implantable Cardioverter Defibrillator Market Pipeline Products 133

Table 71: Pacemaker Market Pipeline Products 134

Table 72: Implantable Cardioverter Defibrillators Market Pipeline Products 135

Table 73: Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products 136

Table 74: Cardiac Valve Repairs Market Pipeline Products 139

Table 75: Septal Occluders Market Pipeline Products 140

Table 76: Cardiovascular Surgery Market Pipeline Products 141

Table 77: Electrophysiology Ablation Catheters Market Pipeline Products 143

Table 78: Electrophysiology Diagnostic Catheters Market Pipeline Products 145

Table 79: Electrophysiology Lab Systems Market Pipeline Products 145

Table 80: Ventricular Assist Devices Market Pipeline Products 146

Table 81: Bare Metal Stents Market Pipeline Products 149

Table 82: PTCA Balloon Market Pipeline Products 150

Table 83: Cardiac Catheter Market Pipeline Products 151

Table 84: Coronary Guidewire Market Pipeline Products 152

Table 85: Arteriotomy Closure Devices Market Pipeline Products 152

Table 86: PTCA Coronary Drug Eluting Balloons Market Pipeline Products 153

Table 87: Intravascular Ultrasound Systems (IVUS) Market Pipeline Products 154

Table 88: Stent Grafts Market Pipeline Products 155

Table 89: Peripheral Vascular Stents Market Pipeline Products 157

Table 90: PTA Balloons Market Pipeline Products 159

Table 91: Synthetic Surgical Grafts Market Pipeline Products 160

Table 92: Peripheral Guidewires Market Pipeline Products 160

Table 93: Inferior Vena Cava Filters (IVCF)Market Pipeline Products 161

Table 94: Peripheral Embolic Protection Devices Market Pipeline Products 162

Table 95: PTA Peripheral Drug Eluting Balloons (DEB) Market Pipeline Products 163

Table 96: Tissue Heart Valves Market Pipeline Products 164

Table 97: Mechanical Heart Valves Market Pipeline Products 165

Table 98: Transcatheter Heart Valves Market Pipeline Products 166

Table 99: ValveXchange Receives Equity Investment From CryoLife 167

Table 100: Flexible Stenting Solutions Receives Investment From Goodman 169

Table 101: St. Jude Medical To Invest In Nanostim 170

Table 102: Toshiba Medical Systems Completes Tender Offer To Acquire Vital Images For $273 Million 171

Table 103: Baxter International To Acquire Prism Pharmaceuticals 173

Table 104: Quest Diagnostics Completes Acquisition Of Celera 175

Table 105: Biomedical Structures Acquir

To order this report:

Cardiovascular Devices Industry: North America Cardiovascular Devices Market Outlook to 2017

Cardiovascular Devices Business News

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com